1.
Clin Case Rep
; 4(12): 1101-1106, 2016 12.
Article
in English
| MEDLINE
| ID: mdl-27980741
ABSTRACT
Central diabetes insipidus (CDI) results from a deficiency of arginine vasopressin (AVP) secretion. It is treated by replacement therapy with the synthetic AVP analogue desmopressin. To prevent heart failure in patients with CDI accompanied by cardiac dysfunction, controlling sodium and water intake is essential, using the minimum effective dose of desmopressin.
2.
Nihon Naika Gakkai Zasshi
; 95(12): 2547-9, 2006 Dec 10.
Article
in Japanese
| MEDLINE
| ID: mdl-17240886